Brevibloc Injection
Product Images NDC 10019-115

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Brevibloc (NDC 10019-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Two-port Intravia Bag (Image 01)

This text appears to be describing a medical device with two ports - a medication port for withdrawing an initial bolus of medication and a delivery port. It is not clear what specific device this refers to or what type of medication is involved.*

FDA Label Image

Brevibloc Structural Formula (Image 02)

FDA Label Image

Representative Container Label 10019-075-87 (Image 03)

This is a medical product labeled as Brevibloc, a premixed injection used for intravenous use to manage heart rate or blood pressure. It contains Esmolol Hydrochloride in Sodium Chloride, with a dosage of 2,000 mg/100 mL (20 mg/mL) for single use only. The solution should be clear and colorless to light yellow, and unused portions should be discarded. The label contains instructions, usual dosage, cautions, warnings, and other important information. It is manufactured by Baxter and made in the USA.*

FDA Label Image

Representative Carton Label 10019-075-87 (Image 04)

This is a pharmaceutical product description of Brevibloc DOUBLE STRENGTH pre-mixed injection. It is a solution containing Esmolol Hydrochloride and Sodium Chloride with a strength of 2,000mg/100ml (20mg/ml), stored at a controlled room temperature, protected from freezing and excessive heat. The product is available in a pack of 10 single-use Intravia containers and is for prescription use only. It includes a Barcode for easy scanning and verification purposes.*

FDA Label Image

Brevibloc Representative Container Label Ndc 10019-055-61 (Image 05)

Brevibloc Premixed Injection is a single-use intravenous solution containing 10mg/mL Esmolol Hydrochloride in Sodium Chloride. It comes in 250 mL Iso-Osmotic containers with no preservatives added. Its pH is adjusted with Sodium Hydroxide or Hydrochloric Acid to 5.0 (4.5.5). The solution is sterile and non-pyrogenic, and caution must be taken to check for leaks before use. Brevibloc Premixed Injection should be discarded if leaks are found or if the solution is not crystal-clear or light yellow. It should not be used in series connections or added with other drugs. It can be stored between 15-30°C. Dosage varies, please check the package insert. For questions, Baxter Healthcare Corporation has a customer service number to call. Rx Only.*

FDA Label Image

Brevibloc Representative Carton Label 1 Of 2 Ndc 10019-055-61 (Image 06)

The text describes 10 single-use INTRAVIA containers of Brevibloc Premixed Injection containing Esmolol Hydrochloride in Sodium Chloride with a dosage of 2,500 mg/250 mL (10 mg/mL). The containers must be stored at a temperature of 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F). The product must be protected from freezing and excessive heat. The product is identified through NDC 10019-055-61 codes printed on the labels and barcodes of the container.*

FDA Label Image

Representative Brevibloc Injection Container Label (Image 07)

This is a product label for Brevibloc, a medication containing Esmolol Hydrochloride in a 100mg/10mL dosage. The medicine comes in a ready-to-use vial and is intended for intravenous use only. The solution is iso-osmotic and contains no preservatives. Any unused portion should be discarded. The label also contains contact information for product inquiries. The lot number and expiration date are included in the text.*

FDA Label Image

Brevibloc Representative Carton Label Ndc 10019-115-01 (Image 08)

Brevibloc Injection is a medication used for intravenous use that contains esmolol hydrochloride. It comes in a pack of 25 single dose vials, each containing 100 mg/10 mL of the medication. The vials are ready-to-use and iso-osmotic. The manufacturer of this medication is Baxter S.*

FDA Label Image

Brevibloc Representative Carton Label Ndc 10019-115-01 (Image 09)

Brevibloc Injection is a medication containing esmolol hydrochloride to be administered intravenously. It comes in ready-to-use vials of 10mg/mL with a total volume of 10mL (100mg). The package contains 25 single-dose vials. Further information regarding dosage and administration is not available due to incomplete scanning.*

FDA Label Image

Brevibloc Representative Carton Label Ndc 10019-115-01 (Image 10)

This is a package of Brevibloc Injection containing four packs, each consisting of 25 ready-to-use vials, with a total of 100 vials of Esmolol Hydrochloride. The concentration of the solution is 100 mg/10 mL. The product should be stored at a temperature of 25°C (77°F) and has an expiration date of DECZUQQ LUT ABCDE12345 Q1Y 4. The manufacturer of the product is Baxter Healthcare Corporation located in Deerfield, IL 60015 USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.